The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study to investigate the demographic characteristics, metabolic control, complications occurrence as well as risk factors of patients with T1D, and to investigate the clinical features, complications' burdens and risk factors in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years.
Study Type
OBSERVATIONAL
Enrollment
20,000
Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center
Gansu Provincial People's Hospital
Lanzhou, Gansu, China
RECRUITINGShenzhen Second People's Hospital
Shenzhen, Guangdong, China
RECRUITINGChange in serum hemoglobin A1c level
A1c reflects the average blood glucose level
Time frame: Every year for up to 10 years
Albumin-to-creatinine ratio in urine sample
Albumin-to-creatinine ratio in urine sample
Time frame: up to 10 years
Arteriosclerotic cardiovascular diseases
Incident cases of cardiovascular diseases
Time frame: up to 10 years
Electromyography
value of nerve conduction velocity, F wave index, H-reflex
Time frame: up to 10 years
PHQ-9
PHQ-9(a score between 0-27, ≥10 may indicate depression)
Time frame: up to 10 years
GAD-7
GAD-7(a score between 0-21, ≥5 may indicate general anxiety)
Time frame: up to 10 years
WHO-5
WHO-5 (a score between 0-100, higher score means better outcome)
Time frame: up to 10 years
PAID
PAID (a score between 0-100, ≥40 warrants special attention).
Time frame: up to 10 years
Change in C-peptide
C-peptide are measured before and 2-hour after a mixed meal tolerance test at each follow-up of this study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hainan General Hospital
Haikou, Hainan, China
RECRUITINGthe First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
RECRUITINGThe First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
RECRUITINGThe Second Xiangya Hospital, Central South University
Changsha, Hunan, China
RECRUITINGThe First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
NOT_YET_RECRUITINGHeji Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
RECRUITINGThe First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
RECRUITINGThe First People's Hospital of Yunnan
Kunming, Yunnan, China
RECRUITING...and 1 more locations
Time frame: Every year for up to 10 years
Change in titer of autoantibodies
Glutamic acid decarboxylase antibody using radioligand binding assay method
Time frame: Every year for up to 10 years
Fasting blood glucose
the blood sugar level after fasting for eight hours
Time frame: Every year for up to 10 years
Systolic blood pressure
Systolic blood pressure
Time frame: Every year for up to 10 years
Diastolic blood pressure
Diastolic blood pressure
Time frame: Every year for up to 10 years
Change in lipid profiles
Including triglyceride, total cholesterol, HDL-cholesterol and LDL-cholesterol
Time frame: Every year for up to 10 years
Metabolomics
un-targeted metabolomics using the LC-MS/MS system
Time frame: Every year for up to 10 years